ProCap Financial, Inc.

ProCap Financial, Inc. reported a net loss of $65.05 million for the three months ended June 30, 2026, with basic net loss per share of $0.73. Revenue for the quarter was $37 thousand. The company completed the acquisition of CFO Silvia, an AI agent lab focused on finance, for $23.3 million in April 2026. Additionally, the fair value of digital assets (Bitcoin) decreased significantly, contributing to a $154.83 million unrealized loss, and the company repurchased $135.4 million of convertible notes.

ProCap Financial, Inc. announced that it has regained compliance with Nasdaq's independent director and audit committee requirements. The company had previously received a deficiency letter from Nasdaq on January 26, 2026, for non-compliance with listing rules. Following the appointment of Benjamin Buchanan to its Board of Directors and audit committee on July 16, 2026, Nasdaq confirmed on July 21, 2026, that the company is now compliant and the matter is closed.

ProCap Financial, Inc. announced the election of Benjamin Buchanan as an independent director to its Board of Directors, effective July 15, 2026. Mr. Buchanan brings extensive strategic, operational, and business experience, having served as CEO of All Current and in senior financial and operational roles at other companies. His appointment to the Audit, Compensation, and Nomination and Governance Committees ensures compliance with Nasdaq Listing Rules regarding Audit Committee composition and independent director majority on the Board.

ProCap Financial reported a net loss of $107.8 million for the first quarter of 2026, primarily driven by a $105.5 million unrealized loss on its Bitcoin holdings. The company's revenue for the quarter was $1,000. Strategically, ProCap launched its AI-driven research platform, ProCap Insights, and acquired CFO Silvia, Inc. in April 2026. Despite the significant loss, the company believes its cash and Bitcoin holdings provide sufficient liquidity for the next year.

ProCap Financial, Inc. entered into a Registration Rights Agreement with CFO Silvia, Inc. and its equity holders, as a condition of their merger agreement. This agreement grants the holders the right to register their shares of ProCap Financial common stock, potentially allowing them to sell their shares in the public market, which could increase liquidity but also dilute existing shareholders.

ProCap Financial, Inc. has entered into a merger agreement to acquire CFO Silvia, Inc. As part of the agreement, shares of CFO Silvia will be converted into shares of ProCap Financial common stock. A registration rights agreement has been established to register the shares of common stock issued pursuant to the merger.

ProCap Financial, Inc. entered into a Registration Rights Agreement with CFO Silvia, Inc. and its equity holders, following a merger agreement dated February 9, 2026. This agreement grants the holders the right to register their shares of ProCap Financial common stock issued as part of the merger, potentially increasing liquidity and providing exit opportunities for these holders.

ProCap Financial, Inc. entered into a Registration Rights Agreement with CFO Silvia, Inc. and certain equity holders following a merger agreement. This agreement grants the holders the right to register their shares of common stock issued pursuant to the merger, providing them with liquidity options and potentially impacting the stock's supply in the market.

ProCap Financial, Inc. entered into a Registration Rights Agreement with CFO Silvia, Inc., certain equity holders of CFO Silvia, and other parties, effective April 6, 2026. This agreement follows a merger agreement dated February 9, 2026, where CFO Silvia's shares will be converted into ProCap Financial's common stock, and aims to register these shares with the holders, potentially increasing liquidity and providing an exit strategy for CFO Silvia's equity holders.

ProCap Financial's Chief Investment Officer, Jeff Park, has resigned effective April 3, 2026. As part of a separation agreement, Park will receive continued base salary through May 8, 2026, and continued vesting of restricted stock units through August 4, 2026, along with healthcare continuation for six months.